AI and HealthCare, Medical Equipment / 11.07.2025
Remote Monitoring in Clinical Research: Benefits and Limitations
[caption id="attachment_69484" align="aligncenter" width="500"]
Photo by MedPoint 24[/caption]
Remote monitoring is rapidly becoming a central component of modern clinical research. Driven by advancements in digital health technologies, wearable sensors, and telecommunication platforms, remote monitoring allows investigators to collect real-time patient data without requiring participants to travel to study sites. This shift toward decentralized clinical trials and virtual monitoring has significant implications for the future of research—making studies more accessible, cost-effective, and representative.
At its core, remote monitoring involves the collection of health-related data from participants outside of traditional clinical settings, using connected devices such as smartwatches, mobile apps, biosensors, and electronic health records (EHRs). Data collected may include vital signs, medication adherence, physical activity, symptom reporting, or even biometric data such as ECGs or glucose levels.
The COVID-19 pandemic accelerated the adoption of remote monitoring, revealing both its vast potential and practical limitations. In 2025 and beyond, the challenge lies in striking a balance—leveraging the benefits while addressing regulatory, technical, and ethical complexities.
Photo by MedPoint 24[/caption]
Remote monitoring is rapidly becoming a central component of modern clinical research. Driven by advancements in digital health technologies, wearable sensors, and telecommunication platforms, remote monitoring allows investigators to collect real-time patient data without requiring participants to travel to study sites. This shift toward decentralized clinical trials and virtual monitoring has significant implications for the future of research—making studies more accessible, cost-effective, and representative.
At its core, remote monitoring involves the collection of health-related data from participants outside of traditional clinical settings, using connected devices such as smartwatches, mobile apps, biosensors, and electronic health records (EHRs). Data collected may include vital signs, medication adherence, physical activity, symptom reporting, or even biometric data such as ECGs or glucose levels.
The COVID-19 pandemic accelerated the adoption of remote monitoring, revealing both its vast potential and practical limitations. In 2025 and beyond, the challenge lies in striking a balance—leveraging the benefits while addressing regulatory, technical, and ethical complexities.
Scott Gray[/caption]
Scott Gray: Founder and CEO of Clincierge, the global leader in patient support services for clinical trials. With a team of patient coordinators around the world, Clincierge helps patients and their caregivers navigate the logistics of clinical trial participation, including prepaid air travel, ground transportation, and lodging as well as rapid reimbursements, translation and interpretation services, and individual solutions for trial participants in remote locations or with complex medical needs. For more information, visit clincierge.com.
MedicalResearch.com: What is the mission of Clincierge?
